Siren L.L.C. - Insider Trades & Share Buys/Sales

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Siren L.L.C.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2026-02-02 Purchase	2026-02-04 4:25 pm	LEXICON PHARMACEUTICALS INC.	LXRX	Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner	1,538,462	$1.3	$2,000,001	42,606,727 (Indirect)	View
2024-12-10 Sale	2024-12-12 4:39 pm	Scholar Rock Holding Corp	SRRK	Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner	1,600,000	$41.65	$66,640,000	9,250,005 (Direct)	View
2024-11-25 Sale	2024-11-27 4:31 pm	Scholar Rock Holding Corp	SRRK	Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner	409,433	$38.49	$15,757,639	10,850,005 (Direct)	View
2024-08-07 Sale	2024-08-09 4:30 pm	GLYCOMIMETICS INC	GLYC	Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner	322,361	$0.18987	$61,206	6,317,565 (Direct)	View
2024-08-05 Sale	2024-08-07 4:30 pm	GLYCOMIMETICS INC	GLYC	Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner	220,255	$0.18698	$41,184	6,639,926 (Direct)	View
2024-08-01 Sale	2024-08-05 4:53 pm	GLYCOMIMETICS INC	GLYC	Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner	349,764	$0.20327	$71,097	6,860,181 (Direct)	View
2024-07-26 Sale	2024-07-30 5:16 pm	GLYCOMIMETICS INC	GLYC	Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner	1,379,119	$0.2286	$315,262	7,209,945 (Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2025-12-11 Exercise	2026-02-06 5:35 pm	N/A N/A	Scholar Rock Holding Corp	SRRK	Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND 10% Owner	1,575,008	$7.35	10,825,013 (Direct)	View
2025-12-11 Exercise	2026-02-06 5:35 pm	2022-06-22 2025-12-31	Scholar Rock Holding Corp	SRRK	Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND 10% Owner	1,575,008	$0	10,825,013 (Direct)	View
2026-02-02 Option Award	2026-02-04 4:25 pm	N/A N/A	LEXICON PHARMACEUTICALS INC.	LXRX	Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner	367,145	$65	42,606,727 (Indirect)	View
2026-02-02 Option Award	2026-02-04 4:25 pm	N/A N/A	LEXICON PHARMACEUTICALS INC.	LXRX	Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner	22,400,000	$1.3	42,606,727 (Indirect)	View
Ownership	2024-07-29 6:03 pm	N/A N/A	Scholar Rock Holding Corp	SRRK	Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner	0	$0	12,834,446 (Direct)	View
Ownership	2024-07-29 5:55 pm	N/A N/A	GLYCOMIMETICS INC	GLYC	Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner	0	$0	8,589,064 (Direct)	View
Ownership	2024-07-29 5:31 pm	N/A N/A	LEXICON PHARMACEUTICALS INC.	LXRX	Siren L.L.C. Invus Global Management LLC Director 10% Owner	0	$0	38,918,903 (Indirect)	View

Siren L.L.C. - Insider Trading & Ownership